|
Fusion Proteins, gag-pol
|
D015685 |
[Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesized only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting.
] |
|
Retroviridae Proteins, Oncogenic
|
D015682 |
[Retroviral proteins that have the ability to transform cells. They can induce sarcomas, leukemias, lymphomas, and mammary carcinomas. Not all retroviral proteins are oncogenic.
] |
|
Gene Products, gag
|
D015683 |
[Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen.
] |
|
Oncogene Protein pp60(v-src)
|
D015688 |
[A tyrosine-specific protein kinase encoded by the v-src oncogene of ROUS SARCOMA VIRUS. The transforming activity of pp60(v-src) depends on both the lack of a critical carboxy-terminal tyrosine phosphorylation site at position 527, and the attachment of pp60(v-src) to the plasma membrane which is accomplished by myristylation of its N-terminal glycine.
] |
|
Oncogene Protein p21(ras)
|
D015689 |
[Transforming protein encoded by ras oncogenes. Point mutations in the cellular ras gene (c-ras) can also result in a mutant p21 protein that can transform mammalian cells. Oncogene protein p21(ras) has been directly implicated in human neoplasms, perhaps accounting for as much as 15-20% of all human tumors. This enzyme was formerly listed as EC 3.6.1.47.
] |
|
Gene Products, env
|
D015686 |
[Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease.
] |
|
Neurocutaneous Syndromes
|
C17.800.827.250.712 |
|
|
Cell Hypoxia
|
D015687 |
[A condition of decreased oxygen content at the cellular level.
] |
|
Liver Failure, Acute
|
C06.552.308.500.750 |
|
|
Indolequinones
|
D03.633.100.473.412 |
|
|
Nobelium
|
D01.496.749.305.100.575 |
|
|
Abbreviated Injury Scale
|
E05.318.308.940.968.875.125 |
|
|
Pneumonia, Pneumocystis
|
C08.381.472.700 |
|
|
Gabapentin
|
D12.125.190.350.225 |
|
|
Halobacillus
|
B03.300.390.400.158.600 |
|
|
Cystic Adenomatoid Malformation of Lung, Congenital
|
D015615 |
[This type is microcystic, characterized by multiple cysts of 0.5 to 2.5 cm.
, This type is characterized by a bulky solid mass with cysts of <0.5 cm.
, This type is macrocystic, characterized by a single or multiple cysts of >2.5 cm.
, An abnormality in lung development that is characterized by a multicystic mass resulting from an adenomatous overgrowth of the terminal BRONCHIOLES with a consequent reduction of PULMONARY ALVEOLI. This anomaly is classified into three types by the cyst size.
] |
|
Histiocytosis, Non-Langerhans-Cell
|
D015616 |
[Group of disorders which feature accumulations of active HISTIOCYTES and LYMPHOCYTES, but where the histiocytes are not LANGERHANS CELLS. The group includes HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; SINUS HISTIOCYTOSIS; xanthogranuloma; reticulohistiocytoma; JUVENILE XANTHOGRANULOMA; xanthoma disseminatum; as well as the lipid storage diseases (SEA-BLUE HISTIOCYTE SYNDROME; and NIEMANN-PICK DISEASES).
] |
|
Hepadnaviridae
|
D015613 |
[A family of hepatotropic DNA viruses which contains double-stranded DNA genomes and causes hepatitis in humans and animals. There are two genera: AVIHEPADNAVIRUS and ORTHOHEPADNAVIRUS. Hepadnaviruses include HEPATITIS B VIRUS, duck hepatitis B virus (HEPATITIS B VIRUS, DUCK), heron hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis B virus (HEPATITIS B VIRUS, WOODCHUCK).
] |
|
Histiocytosis
|
D015614 |
[General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.
] |
|
Sumoylation
|
G05.308.670.600.831.500 |
|
